Home Rheumatology Low Back Pain and Spinal Disease

Low Back Pain and Spinal Disease

🎧 Low Back Pain and Spinal Disease — deep-dive podcast

📋 Key Information Summary

📋
  • Most acute low back pain is mechanical and self-limiting (80-90% resolve within 6 weeks). Reassurance and maintaining activity are first-line.
  • Cauda equina syndrome (saddle anaesthesia, bilateral leg weakness, urinary retention/incontinence) is a surgical emergency requiring urgent MRI and neurosurgical referral.
  • Red flags for serious pathology include: age <20 or >55, history of cancer, unexplained weight loss, fever, IV drug use, prolonged corticosteroid use, and failure to improve after 4-6 weeks.
  • Routine imaging (X-ray, CT, MRI) is NOT indicated for non-specific low back pain without red flags in the first 4-6 weeks.
  • Inflammatory back pain (axSpA) is suggested by: age <45, insidious onset, improvement with exercise, no improvement with rest, and night pain. Refer to rheumatology for HLA-B27 and MRI sacroiliac joints.
  • Lumbar spinal stenosis classically causes neurogenic claudication: bilateral leg pain/numbness worsened by standing/walking and relieved by sitting/flexion (the "shopping trolley sign").
  • Cervical radiculopathy typically presents with dermatomal arm pain, numbness, and weakness. Most cases improve with conservative management (physiotherapy, short-term analgesics).
  • For acute mechanical LBP, first-line pharmacotherapy is regular paracetamol or an NSAID (e.g., naproxen) for a short course. Avoid opioids if possible.
  • Multidisciplinary pain programmes are key for chronic non-specific LBP (>3 months). Focus on active therapies (exercise, CBT) over passive therapies.
  • Aboriginal and Torres Strait Islander peoples experience higher rates of spinal disease, later presentation, and barriers to specialist care. Culturally safe engagement is essential.
  • Consider psychosocial factors (yellow flags) early: fear-avoidance beliefs, catastrophising, and workplace issues. These are strong predictors of chronicity.
🎬 Low Back Pain and Spinal Disease — clinical explainer

Introduction & Australian Epidemiology

Low back pain (LBP) is the leading cause of disability worldwide and a major burden on the Australian healthcare system. Lifetime prevalence is approximately 80%. It is the third most common reason for consulting a GP in Australia. Most episodes are non-specific and mechanical in origin, with a favourable natural history. However, it is a significant driver of work absenteeism, healthcare costs, and long-term opioid use.

This guideline covers key spinal conditions presenting with back and neck pain, emphasising a biopsychosocial model, appropriate investigation, and management within the Australian context. The focus is on early identification of serious pathology, rational use of imaging, and evidence-based conservative care.

⚠️
Key Burden: According to the AIHW, back problems accounted for 3.6% of total disease burden in 2023 and were a leading cause of early retirement and disability pension claims.
Low Back Pain and Spinal Disease clinical infographic — pathophysiology, clinical clues, diagnosis, imaging, and management
Tap or click image to enlarge — Low Back Pain and Spinal Disease: pathophysiology, clinical clues, diagnosis, imaging, and management.
Low Back Pain and Spinal Disease infographic, full size

Mechanical Low Back Pain

Clinical Presentation & Diagnosis

Pain is localised to the lumbosacral region, with or without leg pain (non-radicular). It is typically worsened by movement and load, and relieved by rest. Examination findings are non-specific, with possible paraspinal tenderness and limited range of motion. Neurological exam (straight leg raise, dermatomes, myotomes) should be normal.

Pathophysiology

Often attributed to musculoligamentous strain or facet joint dysfunction, but a specific anatomical source is rarely identifiable. Degenerative changes (disc bulges, facet arthrosis) on imaging are common in asymptomatic individuals and correlate poorly with symptoms.

Management

First-line: Reassurance about good prognosis, advice to remain active, and self-care (heat pack). Avoid bed rest.

💊
Paracetamol
Panadol® · Analgesic
Adult dose 1 g PO 4-6 hourly (max 4 g/day)
Paediatric dose 15 mg/kg/dose PO 4-6 hourly
PBS status ✔ PBS General Benefit
💊
Naproxen
Naprogesic®, Inza® · NSAID
Adult dose 500 mg PO BD, reduce to 250 mg BD when possible
Duration Shortest effective course (max 2 weeks)
PBS status ✔ PBS General Benefit

Second-line / Chronic pain: Consider duloxetine (PBS Authority Required for chronic musculoskeletal pain) or short-course muscle relaxants (e.g., diazepam 2-5 mg nocte, max 7 days). Opioids are generally not recommended for chronic LBP.

Non-pharmacological: Referral for physiotherapy (exercise-based), massage, or chiropractic care for persistent symptoms. CBT for chronic pain with significant psychosocial contributors.

Lumbar Spinal Stenosis

Clinical Presentation

Neurogenic claudication: bilateral or unilateral leg pain, heaviness, numbness, or weakness provoked by standing or walking, and relieved by sitting or spinal flexion (the "shopping trolley sign"). Symptoms often improve when pushing a supermarket trolley. Examination may be normal between episodes; calf wasting or mild weakness may be present.

Diagnosis

Clinical diagnosis supported by imaging. MRI lumbar spine is the gold standard to confirm central canal stenosis and exclude other pathologies. See Imaging Guidelines section.

Management

Conservative (first-line): Supervised physiotherapy (flexion-based exercises, core stability), weight loss, walking aids. Gabapentinoids (e.g., pregabalin) may help neuropathic leg pain.

💊
Pregabalin
Lyrica® · Gabapentinoid
Adult dose 75 mg PO BD, titrate to 150-300 mg BD
Renal adjustment Required (CrCl <60 mL/min)
PBS status ⚠ PBS Restricted Benefit

Surgical referral: Indicated for progressive neurological deficit, severe symptoms refractory to 3-6 months of conservative care, or significant impact on quality of life. Decompressive laminectomy has good outcomes for appropriately selected patients.

Cervical Radiculopathy

Clinical Presentation

Sharp, shooting pain radiating down the arm in a dermatomal pattern, often with associated numbness, paraesthesia, or weakness. Coughing or sneezing may exacerbate pain. Common levels: C6 (thumb, biceps weakness), C7 (middle finger, triceps weakness). Spurling's test may be positive.

Diagnosis & Differential

Primarily clinical. Differentiate from carpal tunnel syndrome, rotator cuff pathology, or Pancoast tumour. MRI cervical spine is indicated if symptoms persist >6 weeks or with progressive neurological deficit.

Management

Most cases (75-90%) improve with conservative care within 6-12 weeks.

  • Analgesia: NSAIDs, simple analgesics. Short course of oral corticosteroids (e.g., prednisone 50 mg daily for 5 days) may reduce acute radicular pain.
  • Physiotherapy: Cervical traction, postural advice, and nerve gliding exercises.
  • Referral: To neurosurgery or orthopaedic spine surgery for: progressive motor weakness, intractable pain, or signs of myelopathy (e.g., gait disturbance, hyperreflexia, upgoing plantars).

Inflammatory Back Pain & Axial Spondyloarthritis (axSpA)

Clinical Features

Inflammatory back pain (IBP) is the hallmark of axSpA. Key features (ASAS criteria): onset <45 years, insidious onset, improvement with exercise, no improvement with rest, and pain at night (with improvement upon getting up).

Diagnosis

Refer to rheumatology. Diagnosis is based on a combination of clinical features, HLA-B27 status, elevated CRP/ESR, and imaging (X-ray sacroiliac joints showing definite sacroiliitis, or MRI showing active inflammation). AxSpA includes radiographic (ankylosing spondylitis) and non-radiographic forms.

Management

First-line: Regular exercise (swimming, Pilates) and NSAIDs (e.g., naproxen, celecoxib). NSAIDs should be taken regularly, not PRN, to control inflammation.

💊
Celecoxib
Celebrex® · COX-2 Selective NSAID
Adult dose 100-200 mg PO BD
PBS status ✔ PBS General Benefit

Beyond NSAIDs: Patients with persistently high disease activity are eligible for PBS-subsidised biologic DMARDs (TNF inhibitors like adalimumab, or IL-17 inhibitors like secukinumab) via Authority Required application. Requires rheumatologist initiation.

Allied health: Regular physiotherapy is a cornerstone of management to maintain mobility and posture.

🖼️ Low Back Pain and Spinal Disease — visual summary
Low Back Pain and Spinal Disease visual summary infographic

Cauda Equina Red Flags

🚨
Surgical Emergency: Cauda equina syndrome (CES) requires emergency MRI and surgical decompression, ideally within 24-48 hours of symptom onset to optimise outcomes for bladder, bowel, and sexual function.

Red Flag Symptoms & Signs

  • Saddle anaesthesia: Altered sensation in the perineum, buttocks, and inner thighs.
  • Bladder dysfunction: Urinary retention (overflow incontinence) or loss of bladder sensation.
  • Bowel dysfunction: Faecal incontinence or loss of anal sphincter tone.
  • Progressive bilateral motor weakness: Especially in the legs (L2-S1 myotomes).
  • Sexual dysfunction: Recent onset impotence or altered genital sensation.

Action

If any red flags are present:

  1. Perform an urgent neurological examination (perianal sensation, anal tone, post-void residual volume).
  2. Arrange emergency MRI lumbar spine.
  3. Refer immediately to the nearest neurosurgical or spinal unit.

Imaging Guidelines

Imaging should be guided by clinical assessment and the presence of red flags. Avoid routine imaging for non-specific LBP.

Indication First-Line Modality Notes & MBS Considerations
Acute LBP, no red flags No imaging Reassess if no improvement after 4-6 weeks.
Suspected cauda equina, infection, malignancy MRI (emergency) Urgent access required. CT myelogram if MRI contraindicated.
Progressive neurological deficit MRI MBS rebate available with appropriate clinical justification (Item 63001 for MRI lumbar).
Suspected axSpA (IBP) X-ray pelvis (AP) for SI joints MRI SI joints for non-radiographic disease. Refer rheumatology first.
Lumbar stenosis work-up MRI lumbar spine Gold standard. CT is alternative if MRI contraindicated.
Cervical radiculopathy, persistent MRI cervical spine If symptoms persist >6 weeks or with motor deficit.
⚠️
MBS Restrictions: Lumbar spine MRI has specific MBS criteria (e.g., failure of conservative management, suspicion of serious pathology). Ensure clinical notes support the request to avoid patient co-payment.

Special Populations

🤰
Pregnancy

LBP/PGP: Common. Use paracetamol as first-line. NSAIDs generally avoided, especially in 3rd trimester. Physiotherapy and pelvic belts are safe.

Imaging: Ultrasound first. MRI (without gadolinium) preferred over CT if needed.

👶
Paediatrics

Back pain in children: Uncommon. Always consider serious pathology (tumour, infection, spondylolysis). Pain lasting >4 weeks warrants investigation.

Spondylolysis/Spondylolisthesis: Common in adolescent athletes (gymnastics, cricket). Requires SPECT/CT or MRI for diagnosis.

👴
Elderly

Osteoporotic Vertebral Fracture: May present with acute LBP after minimal trauma. DXA scan for osteoporosis assessment. Use with caution: NSAIDs (renal/GI risk), opioids (fall risk).

Spinal Stenosis: Prevalence increases with age. Surgical outcomes can be good but must be weighed against comorbidities.

🩸
Renal Impairment

NSAIDs: Avoid if eGFR <30. Use paracetamol. Pregabalin requires dose adjustment.

🫁
Hepatic Impairment

Paracetamol: Max 2 g/day in severe liver disease. Avoid NSAIDs if cirrhosis. Duloxetine is contraindicated in significant liver disease.

🛡️
Immunocompromised

Spinal Infection: Lower threshold for MRI. Presents with localised pain, fever, elevated inflammatory markers. Common organisms: Staph. aureus (including MRSA).

Aboriginal and Torres Strait Islander Health Considerations

Aboriginal and Torres Strait Islander Health

Aboriginal and Torres Strait Islander peoples experience a higher prevalence of back pain, greater severity, and more significant functional impact. This is compounded by socioeconomic disadvantage, barriers to accessing timely care, and historical distrust of the healthcare system.

Access to Specialist Care
Significant geographic and financial barriers, especially in remote communities. Telehealth for rheumatology and pain medicine consultations can be utilised where appropriate.
Cultural Safety
Management plans must be co-developed. Involve Aboriginal Health Workers/Practitioners and local ACCHOs. Understand concepts of family and community in care decisions.
Comorbidities
Higher rates of diabetes, renal disease, and cardiovascular disease impact analgesic choice (e.g., NSAID caution). Social and emotional wellbeing must be addressed.
Opioid Risk
Exercise extreme caution with opioid prescribing due to higher risks of harm and dependence. Prioritise non-pharmacological strategies and supported self-management.
📊 Low Back Pain and Spinal Disease — slide deck

Open slides PDF in new tab

📚 References

  1. 1. Australian Institute of Health and Welfare (AIHW). Back problems. Canberra: AIHW; 2023.
  2. 2. National Health and Medical Research Council (NHMRC). Australian Acute Musculoskeletal Pain Guidelines. Canberra: NHMRC; 2003 (updated 2020).
  3. 3. Royal Australian College of General Practitioners (RACGP). Low back pain: clinical care standard. Melbourne: RACGP; 2022.
  4. 4. Australian Commission on Safety and Quality in Health Care (ACSQHC). Lumbar Spine MRI Clinical Care Standard. Sydney: ACSQHC; 2023.
  5. 5. Lin I, Wiles L, Waller R, et al. What does best practice care for musculoskeletal pain look like? Eleven consistent recommendations from high-quality clinical practice guidelines: systematic review. Br J Sports Med. 2020;54(2):79-86.
  6. 6. Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017;390(10089):73-84.
  7. 7. Australian Rheumatology Association (ARA). Biological DMARDs for axial spondyloarthritis: information for prescribers. 2024.
  8. 8. Lurie J, Tomkins-Lane C. Management of lumbar spinal stenosis. BMJ. 2016;352:h6234.
  9. 9. Medicare Benefits Schedule (MBS) Online. MRI lumbar spine (Item 63001). Australian Government Department of Health. Accessed 2024.
  10. 10. Painaustralia. National Pain Strategy. 2019.